Algert Global LLC Boosts Stake in Intuitive Surgical, Inc. $ISRG

Algert Global LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.5% during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,815 shares of the medical equipment provider’s stock after acquiring an additional 3,010 shares during the quarter. Algert Global LLC’s holdings in Intuitive Surgical were worth $7,073,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. Kilter Group LLC purchased a new stake in Intuitive Surgical in the second quarter valued at approximately $27,000. Greykasell Wealth Strategies Inc. purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $27,000. Caitlin John LLC purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $30,000. Guerra Advisors Inc bought a new position in shares of Intuitive Surgical in the 3rd quarter worth $37,000. Finally, Riggs Asset Managment Co. Inc. raised its position in shares of Intuitive Surgical by 84.2% during the 2nd quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after buying an additional 32 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 2.4%

ISRG stock opened at $483.46 on Tuesday. The stock has a market capitalization of $171.69 billion, a price-to-earnings ratio of 61.28, a PEG ratio of 3.64 and a beta of 1.66. The firm’s 50-day moving average price is $511.60 and its two-hundred day moving average price is $513.03. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion during the quarter, compared to analyst estimates of $2.72 billion. During the same period in the prior year, the business posted $2.21 earnings per share. Intuitive Surgical’s revenue for the quarter was up 18.8% on a year-over-year basis. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In other Intuitive Surgical news, SVP Mark Brosius sold 2,362 shares of the company’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the transaction, the senior vice president directly owned 3,554 shares in the company, valued at approximately $1,772,308.72. This represents a 39.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Fredrik Widman sold 133 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at $326,673.60. The trade was a 16.77% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 32,943 shares of company stock valued at $17,279,568. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on ISRG. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a report on Monday, January 26th. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. BTIG Research reaffirmed a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research note on Friday, January 23rd. Royal Bank Of Canada upped their price objective on Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, Zacks Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.